Simone Parello

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.

Interleukin-23 Inhibitors in Inflammatory Bowel Disease.

Showing 1-12 of 12

Last Updated: 09/26/2026